CN102579432A - 3-甲基-1-苯基-2-吡唑啉-5-酮与2-莰醇组合物的新应用 - Google Patents
3-甲基-1-苯基-2-吡唑啉-5-酮与2-莰醇组合物的新应用 Download PDFInfo
- Publication number
- CN102579432A CN102579432A CN2011100053630A CN201110005363A CN102579432A CN 102579432 A CN102579432 A CN 102579432A CN 2011100053630 A CN2011100053630 A CN 2011100053630A CN 201110005363 A CN201110005363 A CN 201110005363A CN 102579432 A CN102579432 A CN 102579432A
- Authority
- CN
- China
- Prior art keywords
- edaravone
- injection
- borneolum syntheticum
- group
- baras camphor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110005363.0A CN102579432B (zh) | 2011-01-12 | 2011-01-12 | 3-甲基-1-苯基-2-吡唑啉-5-酮与2-莰醇组合物的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110005363.0A CN102579432B (zh) | 2011-01-12 | 2011-01-12 | 3-甲基-1-苯基-2-吡唑啉-5-酮与2-莰醇组合物的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102579432A true CN102579432A (zh) | 2012-07-18 |
CN102579432B CN102579432B (zh) | 2016-05-11 |
Family
ID=46469042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110005363.0A Active CN102579432B (zh) | 2011-01-12 | 2011-01-12 | 3-甲基-1-苯基-2-吡唑啉-5-酮与2-莰醇组合物的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102579432B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106668004A (zh) * | 2015-11-06 | 2017-05-17 | 江苏先声药业有限公司 | 依达拉奉和(+)2-莰醇搽剂及其制备方法 |
CN106727287A (zh) * | 2015-11-23 | 2017-05-31 | 江苏先声药业有限公司 | 依达拉奉和天然冰片的高浓度注射液 |
WO2018040989A1 (zh) * | 2016-08-29 | 2018-03-08 | 烟台益诺依生物医药科技有限公司 | 依达拉奉与(+)-2-莰醇的舌下用药物组合物 |
CN112206229A (zh) * | 2019-07-11 | 2021-01-12 | 烟台益诺依生物医药科技有限公司 | 一种组合物在制备治疗脂肪肝、肝炎和肝纤维化中的应用 |
WO2022007831A1 (zh) * | 2020-07-08 | 2022-01-13 | 先声药业有限公司 | 一种组合物的医药用途 |
WO2023078325A1 (zh) * | 2021-11-08 | 2023-05-11 | 南京宁丹新药技术有限公司 | 一种含有依达拉奉右莰醇组合物在治疗认知障碍中的应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101524352A (zh) * | 2008-03-04 | 2009-09-09 | 江苏先声药物研究有限公司 | 一种含有3-甲基-1-苯基-2-吡唑啉-5-酮的组合物 |
CN101933899A (zh) * | 2010-08-26 | 2011-01-05 | 南京先声东元制药有限公司 | 一种依达拉奉注射液及其制备方法 |
-
2011
- 2011-01-12 CN CN201110005363.0A patent/CN102579432B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101524352A (zh) * | 2008-03-04 | 2009-09-09 | 江苏先声药物研究有限公司 | 一种含有3-甲基-1-苯基-2-吡唑啉-5-酮的组合物 |
CN101933899A (zh) * | 2010-08-26 | 2011-01-05 | 南京先声东元制药有限公司 | 一种依达拉奉注射液及其制备方法 |
Non-Patent Citations (1)
Title |
---|
万晓霞: "冰片药理学研究进展", 《广东药学院学报》 * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106668004A (zh) * | 2015-11-06 | 2017-05-17 | 江苏先声药业有限公司 | 依达拉奉和(+)2-莰醇搽剂及其制备方法 |
CN106727287A (zh) * | 2015-11-23 | 2017-05-31 | 江苏先声药业有限公司 | 依达拉奉和天然冰片的高浓度注射液 |
CN106727287B (zh) * | 2015-11-23 | 2020-01-24 | 江苏先声药业有限公司 | 依达拉奉和天然冰片的高浓度注射液 |
KR20190031316A (ko) * | 2016-08-29 | 2019-03-25 | 옌타이 예네파마 컴퍼니, 리미티드 | 에다라본 및 (+)-2-보르네올의 설하 약학 조성물 |
CN109906077A (zh) * | 2016-08-29 | 2019-06-18 | 烟台益诺依生物医药科技有限公司 | 依达拉奉与(+)-2-莰醇的舌下用药物组合物 |
AU2017317950B2 (en) * | 2016-08-29 | 2019-09-19 | Neurodawn Pharmaceutical Co., Ltd. | Sublingual pharmaceutical composition of edaravone and (+)-2-borneol |
WO2018040989A1 (zh) * | 2016-08-29 | 2018-03-08 | 烟台益诺依生物医药科技有限公司 | 依达拉奉与(+)-2-莰醇的舌下用药物组合物 |
CN109906077B (zh) * | 2016-08-29 | 2020-02-07 | 烟台益诺依生物医药科技有限公司 | 依达拉奉与(+)-2-莰醇的舌下用药物组合物 |
KR102216381B1 (ko) | 2016-08-29 | 2021-02-18 | 옌타이 예네파마 컴퍼니, 리미티드 | 에다라본 및 (+)-2-보르네올의 설하 약학 조성물 |
US11135199B2 (en) | 2016-08-29 | 2021-10-05 | Neurodawn Pharmaceutical Co., Ltd. | Sublingual pharmaceutical compositions of edaravone and (+)-2-borneol |
CN112206229A (zh) * | 2019-07-11 | 2021-01-12 | 烟台益诺依生物医药科技有限公司 | 一种组合物在制备治疗脂肪肝、肝炎和肝纤维化中的应用 |
WO2022007831A1 (zh) * | 2020-07-08 | 2022-01-13 | 先声药业有限公司 | 一种组合物的医药用途 |
WO2023078325A1 (zh) * | 2021-11-08 | 2023-05-11 | 南京宁丹新药技术有限公司 | 一种含有依达拉奉右莰醇组合物在治疗认知障碍中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102579432B (zh) | 2016-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102579432A (zh) | 3-甲基-1-苯基-2-吡唑啉-5-酮与2-莰醇组合物的新应用 | |
JP7469400B2 (ja) | 創傷治癒を促進するための局所製剤 | |
US10342797B2 (en) | Solubility of therapeutic agents | |
Patumraj et al. | Comparative effects of garlic and aspirin on diabetic cardiovascular complications | |
Tsai et al. | Myocardial Protective Effect of Honokiol: An Active Component in Magnolia ofpcinalis | |
EP0774255B1 (en) | Use of ursolic acid for the manufacture of a medicament for suppressing metastasis | |
Baluchnejadmojarad et al. | Garlic extract attenuates time-dependent changes in the reactivity of isolated aorta in streptozotocin-diabetic rats | |
AU2016318815A1 (en) | The use of kauranes compounds in the manufacture of medicament for treatment of cardiac hypertropy and pulmonary hypertension | |
RU2257383C2 (ru) | Лечение эмфиземы с помощью ретиноидных агонистов (rar), обладающих избирательным действием | |
JP2014185161A (ja) | シロスタゾールを含むカルボスチリル誘導体の脂肪肝治療剤 | |
WO2020021545A1 (en) | Cannabidiol and glucosamine for treating inflammatory joint diseases | |
DD267187A5 (de) | Verfahren zur herstellung von mitteln zur bekaempfung des asthma bronchiale und der chonisch obstruktiven bronchitis | |
EP2190430A1 (de) | Verwendung von von cycloheximid abgeleiteten verbindungen zur behandlung oder vorbeugung von insbesondere ischämien und herzerkrankungen | |
US20220202890A1 (en) | Formulation containing cornus wilsoniana extract and use thereof | |
CN101367799B (zh) | 苦参碱丹参酚酸b复盐和苦参素丹参酚酸b复盐及其制备方法和用途 | |
JP2002534379A (ja) | 新規なブレチリウム組成物およびキットならびに心血管症状の予防および治療におけるそれらの使用 | |
WO2016131321A1 (zh) | Nadph在制备治疗心脑血管疾病的药物中的应用 | |
CN108939052B (zh) | 艾塞那肽在制备预防或治疗房颤的药物中的用途 | |
CN113244405B (zh) | 佛司可林/异佛司可林与五环三萜类化合物的药物组合物及其应用 | |
EP3370756B1 (en) | Combination of canrenoate and exenatide | |
US20050043274A1 (en) | Pharmaceutical compositions and methods for lowering blood pressure and pulse rate | |
US5854287A (en) | D-Propranolol metabolites useful for antioxidant activities | |
CN101070338A (zh) | 丹参酮ⅱa磺酸钾用于制备预防和治疗心肌缺血缺氧、脑缺血缺氧的药物 | |
JP2007536256A (ja) | 心臓損傷の処置のためのピロロキノリンキノン薬およびその使用方法 | |
CN107737108A (zh) | 一种治疗心肌梗死后心室重塑的口服药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160715 Address after: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18 Patentee after: Jiangsu Simcere Pharmaceutical Co., Ltd. Address before: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18 Patentee before: Jiangsu Simcere Pharmaceutical Research Company Limited |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180524 Address after: 211800 8 Xing Long Road, Pukou Economic Development Zone, Nanjing, Jiangsu. Co-patentee after: Jiangsu Simcere Pharmaceutical Co., Ltd. Patentee after: Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. Address before: 210042 699 Xuanwu Road, Xuanwu District, Nanjing, Jiangsu -18 Patentee before: Jiangsu Simcere Pharmaceutical Co., Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: No.99, Huakang Road, Jiangbei new district, Nanjing, Jiangsu Province, 210032 Patentee after: SIMCERE PHARMACEUTICAL Group Patentee after: JIANGSU SIMCERE PHARMACEUTICAL Co.,Ltd. Address before: 211800 Nanjing, Pukou Economic Development Zone, Jiangsu Road, No. 8 Patentee before: NANJING SIMCERE DONGYUAN PHARMACEUTICA Co.,Ltd. Patentee before: JIANGSU SIMCERE PHARMACEUTICAL Co.,Ltd. |